Mogrify strengthens leadership team Cambridge-based Mogrify Limited announced the appointment of Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. more ➔
New CSO for Cellbox Solutions Since October, Dr. Gisèle Deblandre has strengthened the team of Cellbox Solutions GmbH in Norderstedt near Hamburg as Chief Scientific Officer. more ➔
Change in Solys BioDyne ManagementAt the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board. more ➔
Byondis with new Senior Director Timo van den Berg is the new senior director Immuno-Oncology Research and Development at Byondis B.V. He joined the company at beginning more ➔
New head for Orbit Discovery Dr Neil Butt is the new Chief Executive Officer at Oxford-based Orbit Discovery. more ➔
Nordic Nanovector with Interim CEO Malene Brondberg, Chief Financial Officer of Nordic Nanovector since May 2020, became Interim Chief Executive Officer of the company. more ➔
Azafaros appoints Stefano Portolano as CEO Dr Stefano Portolano, M.D., is the new Chief Executive Officer of Azafaros and has been appointed to the Board of Directors of the Dutch company. more ➔
AFB strengthens finance division At the beginning of June, Sidonie Fabre strengthens Advent France Biotechnology (AFB) as new Chief Financial Officer. more ➔
Oxurion: CFO now CEO Tom Graney, until now CFO of Belgian Oxurion nv, took over from CEO Patrik De Haes. De Haes becomes Non-executive Chairman of the Biopharmaceutical company, spezialised in retinal disorders. more ➔
AELIX: Next stage with new CEOBarcelona-based Aelix Therapeutics has appointed Dr Melanie Rolli as CEO. Her predecessor, Dr Jose Luis Cabero, had decided to step down from executive positions at Aelix more ➔
